АНАЛИЗ РЕАЛИЗАЦИИ ПРОГРАММ ЛЕКАРСТВЕННОГО ОБЕСПЕЧЕНИЯ ФЕДЕРАЛЬНЫХ И РЕГИОНАЛЬНЫХ ЛЬГОТОПОЛУЧАТЕЛЕЙ, СТРАДАЮЩИХ САХАРНЫМ ДИАБЕТОМ 2 ТИПА В КАБАРДИНО-БАЛКАРСКОЙ РЕСПУБЛИКЕ

Abstract

Diabetes mellitus refers to a group of metabolic diseases with chronic hyperglycemia due to impaired insulin secretion or function. At the present stage, many countries are on the threshold of a global "epidemic" of diabetes mellitus. Chronic hyperglycemia leads to damage and failure of various organs and tissues. Therefore, diabetes mellitus, and especially its most common form - type 2 diabetes (DM2), is a serious medical and social problem. An effective approach to therapy of DM2 is highly relevant and depends on many factors and pathogenetic mechanisms. But despite the great progress in this direction, there are still many unresolved issues concerning individualization of treatment, creation of new or selection of already available drugs. This study is devoted to the dynamic analysis of prescription forms prescribed and dispensed to patients suffering from DM2 in the Kabardino-Balkar Republic for 2020-2023. The study found an increase in the total volume of drugs dispensed, the financial volume of expenditures on pharmaceutical care for diabetics with DM2 and costs per patient per year. A significant increase in the number of DM2 patients during the study period is shown. The analysis of prescriptions of oral medicines revealed the continuing trends of predominance of sugar-lowering therapy in medical organizations of the Republic of traditional approaches. Innovative drugs are available only to a small number of patients. It is concluded that the current situation with drug assistance to patients suffering from DM2 requires special attention and control on the part of the republic's health care authorities.